Amazon One Medical introduces weight management program

Amazon (AMZN) announced the launch of a comprehensive GLP-1 Management Program through Amazon One Medical that integrates primary care, pharmacy services, and virtual care options to help patients achieve lasting weight loss results. Amazon says its new program addresses these challenges by connecting GLP-1 management with primary care and Amazon Pharmacy in one place, adding that the new program integrates GLP-1 management into patients’ broader primary care relationship, proactively managing how weight loss intersects with cardiovascular health, metabolic conditions, and overall health. The program is available now at Amazon One Medical locations across the U.S. Amazon Pharmacy said it now offers the newly FDA-approved Wegovy and Foundayo oral GLP-1 pills for weight management, with insurance coverage starting as low as $25 per month or cash-pay options starting at $149 per month for both oral medications. Amazon Pharmacy also provides Wegovy injectables, Zepbound auto-injector, and KwikPen-a multi-dose injectable delivering a full month of medication in a single device, with cash-pay pricing starting at $299 per month. All medications are available for fast delivery to all 50 states, with Same-Day Delivery to nearly 3,000 cities and towns today and expanding to nearly 4,500 by the end of 2026. The Fly notes that shares of Hims & Hers (HIMS), which sells peptide-based products, are down 6.3% in premarket trading.

Claim 30% Off TipRanks